Investigation of COVID-19 By Theoretical Docking of Medicines With Two Proteins | ||||
| Egyptian Journal of Chemistry | ||||
| Volume 65, Issue 131, December 2022, Page 247-253 PDF (584.9 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejchem.2022.117309.5292 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Ammar A. Ibrahim   1; Mohammed F. Haddad2; Maher A. Ibrahim3; Ali W. Kasim4
| ||||
| 1Department of Chemistry, College of Science, University of Mosul, Mosul, Iraq | ||||
| 2Northern Technical University, IRAQ | ||||
| 3Department of Biochemistry, College of Medicine, University of Mosul, IRAQ | ||||
| 4Ministry of Health, IRAQ | ||||
| Abstract | ||||
| This study examined the docking of two inhibition for SARS-Cov-2 virus (or COVID-19) these proteins are (6wtt and 6xa4) with nine pharmaceutical compounds (Aminoglutethimide, 4-Aminosalicylic acid, Felbamate, Hydroflumethiazide, Modafinil, Nepafenac, Oxcarbazepine, and Trichlormethiazide) which are used in the general human's life. These pharmaceuticals having different active groups in the structure conformation like (-NH2) and (-OH). Docking was applied the investigate the interaction between these medicines with the proteins using Molecular Operating Environment software (MOE). | ||||
| Keywords | ||||
| COVID-19; Docking; Proteins; ligand-receptor interaction | ||||
|
Statistics Article View: 481 PDF Download: 186 |
||||
